UA105827C2 - Терапевтична комбінація теоброміну і антигістаміну, який діє на н1-рецептор - Google Patents

Терапевтична комбінація теоброміну і антигістаміну, який діє на н1-рецептор

Info

Publication number
UA105827C2
UA105827C2 UAA201208623A UAA201208623A UA105827C2 UA 105827 C2 UA105827 C2 UA 105827C2 UA A201208623 A UAA201208623 A UA A201208623A UA A201208623 A UAA201208623 A UA A201208623A UA 105827 C2 UA105827 C2 UA 105827C2
Authority
UA
Ukraine
Prior art keywords
heading
antihistamine
theobromine
herapeutic
receptor
Prior art date
Application number
UAA201208623A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Джон Брю
Робін Марк Банністер
Original Assignee
Байокоупі Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байокоупі Лімітед filed Critical Байокоупі Лімітед
Publication of UA105827C2 publication Critical patent/UA105827C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
UAA201208623A 2009-12-14 2010-12-14 Терапевтична комбінація теоброміну і антигістаміну, який діє на н1-рецептор UA105827C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052086 WO2011073647A1 (en) 2009-12-14 2010-12-14 Therapeutic combinations of theobromine and an antihistamine

Publications (1)

Publication Number Publication Date
UA105827C2 true UA105827C2 (uk) 2014-06-25

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201208623A UA105827C2 (uk) 2009-12-14 2010-12-14 Терапевтична комбінація теоброміну і антигістаміну, який діє на н1-рецептор

Country Status (18)

Country Link
EP (1) EP2512472A1 (enExample)
JP (2) JP2013513652A (enExample)
CN (1) CN102802625A (enExample)
AU (1) AU2010332495C1 (enExample)
BR (1) BR112012014159A8 (enExample)
CA (1) CA2784215A1 (enExample)
CO (1) CO6541638A2 (enExample)
GB (1) GB0921803D0 (enExample)
IL (1) IL220384A0 (enExample)
MX (1) MX2012006624A (enExample)
NZ (1) NZ600267A (enExample)
PE (1) PE20121538A1 (enExample)
PH (1) PH12012501200A1 (enExample)
RU (1) RU2012129675A (enExample)
SG (2) SG181603A1 (enExample)
UA (1) UA105827C2 (enExample)
WO (1) WO2011073647A1 (enExample)
ZA (1) ZA201204294B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
CN103263533B (zh) * 2013-05-31 2014-11-05 杨宏伟 一种治疗咳嗽的可可碱组合物及其用途及其制剂
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂
CN104224819B (zh) * 2014-09-18 2016-08-17 中山大学 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE59550T1 (de) * 1986-04-17 1991-01-15 Alza Corp Chlorpheniramine therapie.
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
JPH10316568A (ja) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003012514A (ja) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
US20080254029A1 (en) * 2007-04-11 2008-10-16 Alcon Research, Ltd. Use of an Inhibitor of TNFa Plus an Antihistamine to Treat Allergic Rhinitis and Allergic Conjunctivitis

Also Published As

Publication number Publication date
PE20121538A1 (es) 2012-12-21
CA2784215A1 (en) 2011-06-23
NZ600267A (en) 2013-07-26
IL220384A0 (en) 2012-08-30
WO2011073647A1 (en) 2011-06-23
RU2012129675A (ru) 2014-01-27
SG10201408374WA (en) 2015-01-29
JP6078605B2 (ja) 2017-02-08
AU2010332495B2 (en) 2015-01-22
JP2013513652A (ja) 2013-04-22
AU2010332495A1 (en) 2012-06-21
CO6541638A2 (es) 2012-10-16
JP2016040280A (ja) 2016-03-24
BR112012014159A2 (pt) 2017-08-29
EP2512472A1 (en) 2012-10-24
PH12012501200A1 (en) 2012-11-26
AU2010332495C1 (en) 2016-02-11
GB0921803D0 (en) 2010-01-27
MX2012006624A (es) 2012-10-05
BR112012014159A8 (pt) 2017-12-26
CN102802625A (zh) 2012-11-28
SG181603A1 (en) 2012-07-30
ZA201204294B (en) 2013-02-27

Similar Documents

Publication Publication Date Title
UA105827C2 (uk) Терапевтична комбінація теоброміну і антигістаміну, який діє на н1-рецептор
NZ619520A (en) Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
UA96124C2 (ru) Фармацевтический пенный состав, который включает имиквимод
AP2507A (en) Quinoline derivatives and use thereof as mycobacterial inhibitors.
LT2679676T (lt) Būdai ir organizmai, skirti nuo auginimo priklausomai 1,4-butandiolo gamybai
WO2011127070A3 (en) IRE-1α INHIBITORS
IL180872A0 (en) Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
EP2024018A4 (en) PORTABLE ARRANGEMENTS, SYSTEMS AND METHOD FOR PROVIDING FUNCTIONAL OR THERAPEUTIC NEUROSTIMULATION
TNSN08178A1 (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
WO2006011810A3 (en) Mr imaging method for the discrimination between healthy and tumour tissue
UA93903C2 (ru) Производные тетрагидроизохинолина для повышения функции памяти
PH12013500392A1 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy
PL2410047T3 (pl) Oksydoreduktaza i jej zastosowanie do redukcji sekodionu
WO2009149058A8 (en) Modified release niacin formulations
WO2011058373A3 (en) Drug combination with theobromine and its use in therapy
WO2012054093A3 (en) Acyl piperidine inhibitors of soluble epoxide hydrolase
PH12012501203A1 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
EP2033650A4 (en) INHIBITOR OF EXPRESSION OF AP-1 NUCLEAR TRANSCRIPTION FACTOR, AND PHARMACEUTICAL OR OTHER PRODUCTS USING THE INHIBITOR
UA105940C2 (uk) Лікарська комбінація з теоброміном та опіатом і її використання в лікуванні кашлю
HK1214760A1 (zh) 用於消除体内血癌干细胞以及用於防止血癌复发的抗癌试剂如酪氨酸激酶和stat5拮抗剂优选为噻唑烷二酮的组合
WO2010120817A3 (en) Nanochanneled device and related methods
TW200631584A (en) A medicament related to mirtazapine for the treatment of hot flush
GB201219334D0 (en) Catheter having inflation and deflation lumen useful for preventing or reducing reperfusion injury
WO2012040444A3 (en) Treatment of patients with incipient alzheimer's disease
TW200635934A (en) Amorphous tacrolimus and preparation thereof